Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis

被引:0
|
作者
Liu, Zhiyao [1 ]
Huang, Hailiang [1 ]
Yu, Ying [2 ]
Jia, Yuqi [1 ]
Li, Lingling [1 ]
Shi, Xin [1 ]
Wang, Fangqi [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan 250355, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan 250355, Shandong, Peoples R China
关键词
Colchicine; coronavirus disease-19; non-small cell lung cancer; network pharmacology; bioinformatics analysis; molecular docking; molecular dynamics simulation; INTERLEUKIN-17; DISEASE; LESIONS; GENES; IL-17; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colchicine is an alkaloid with antitumor effect isolated from Colchicum autumnale plants, it has been reported in multiple studies as a potential treatment for coronavirus disease-19 and this study applied network pharmacology and bioinformatics analysis to explore the potential mechanism of colchicine against non-small cell lung cancer and coronavirus disease-19. The R software was used to determine the differentially expressed genes of non-small cell lung cancer/coronavirus disease-19, and carry out prognostic analysis and clinical analysis of the differentially expressed genes, the targets of colchicine were obtained from various databases, the protein-protein interaction network of intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 was constructed, enrichment analysis of gene ontology and kyoto encyclopedia of genes and genomes pathways was performed by Metascape database and the molecular docking and molecular dynamics simulation were completed. We obtained a total of 716 differentially expressed genes and identified 13 potential prognostic genes associated with the clinical characterization of non-small cell lung cancer/coronavirus disease-19 patients. C-C motif chemokine ligand 2, toll like receptor 4, intercellular adhesion molecule 1, peroxisome proliferator activated receptor gamma, interleukin 17A, interferon gamma, angiotensin I converting enzyme, fos proto-oncogene, nuclear factor kappa B inhibitor alpha, TIMP metallopeptidase inhibitor 1 and secreted phosphoprotein 1 were core targets. The intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 were mainly enriched in biological processes such as inflammatory response, response to cytokine and response to lipopolysaccharide, as well as signal pathways such as interleukin 17 signaling pathway, hypoxia inducible factor 1 signaling pathway and nucleotide binding oligomerization domain-like receptor signaling pathway. The results of molecular docking showed that the colchicine is better combined with the core targets. Analysis of molecular dynamics simulation showed that the protein and ligand form a stabilizing effect. Based on bioinformatics analysis and network pharmacology, we obtained biomarkers that may be used for the prognosis of non-small cell lung cancer/coronavirus disease-19 patients and revealed that colchicine may play a potential role in the treatment of non-small cell lung cancer/coronavirus disease-19 by regulating multiple targets and multiple signaling pathways and participating in multiple biological processes.
引用
收藏
页码:199 / 216
页数:18
相关论文
共 50 条
  • [1] The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
    Xie, Han
    Huang, Guirui
    Zou, Jianhua
    Zhu, Qianru
    Liang, Zimao
    Huang, Xingxing
    Zhai, Xiangyang
    Zhang, Ruonan
    Chen, Bi
    Li, Keshuai
    Sui, Xinbing
    Yu, Lili
    Cui, Hongsheng
    Wu, Qibiao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19
    Yang, Wuxia
    Zhang, Yichao
    Gao, Jing
    Hu, Pengcheng
    Yang, Yanjie
    Xu, Xiaoqing
    FRONTIERS IN MEDICINE, 2023, 10
  • [3] Network Pharmacology and In Vitro Verification on the Mechanism of Montanine Against Non-Small Cell Lung Cancer
    Iksen, Iksen
    Pongrakhananon, Varisa
    CANCER SCIENCE, 2025, 116 : 1350 - 1350
  • [4] Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis
    Liu, Zhiyao
    Huang, Hailiang
    Yu, Ying
    Jia, Yuqi
    Li, Lingling
    Shi, Xin
    Wang, Fangqi
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (16) : 1274 - 1292
  • [5] Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer
    Yuan, Chong
    Wang, Meng-Heng
    Wang, Fei
    Chen, Peng-Yu
    Ke, Xin-Ge
    Yu, Bing
    Yang, Yan-Fang
    You, Peng-Tao
    Wu, He-Zhen
    LIFE SCIENCES, 2021, 270
  • [6] Network pharmacology and molecular docking reveal the mechanism of action of Bergapten against non-small cell lung cancer
    Chen, Yihao
    Fu, Yu
    Zou, Hongbo
    Wang, Pingsong
    Xu, Yao
    Xie, Qichao
    ONCOLOGY LETTERS, 2025, 29 (02)
  • [7] Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19
    Zhuang, Zhenjie
    Zhong, Xiaoying
    Chen, Qianying
    Chen, Huiqi
    Liu, Zhanhua
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
    Zhang, Wentao
    Yang, Zhe
    Zhou, Fengge
    Wei, Yanjun
    Ma, Xiaoqing
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
    Wu, Wen-yu
    Jiao, Xin
    Song, Wen-xin
    Wu, Peng
    Xiao, Pei-qi
    Huang, Xiu-fang
    Wang, Kai
    Zhan, Shao-feng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] Clinical efficacy and potential mechanism of ginseng polysaccharides in the treatment of non-small cell lung cancer based on meta-analysis associated with network pharmacology
    Zhao, Qi
    Bai, Le
    Zhu, Dongwei
    Li, Tingyuan
    Xu, Jie
    Xu, Yong
    Zhou, Xianmei
    HELIYON, 2024, 10 (06)